Centogene N.V. (CNTG)
NASDAQ: CNTG · IEX Real-Time Price · USD
0.461
-0.019 (-3.96%)
At close: Apr 24, 2024, 4:00 PM
0.480
+0.019 (4.12%)
After-hours: Apr 24, 2024, 4:37 PM EDT

Centogene Statistics

Total Valuation

Centogene has a market cap or net worth of $12.85 million. The enterprise value is $61.83 million.

Market Cap 12.85M
Enterprise Value 61.83M

Important Dates

The last earnings date was Thursday, September 7, 2023, before market open.

Earnings Date Sep 7, 2023
Ex-Dividend Date n/a

Share Statistics

Centogene has 27.87 million shares outstanding.

Shares Outstanding 27.87M
Owned by Insiders (%) 2.73%
Owned by Institutions (%) 65.22%
Float 9.60M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.23
Forward PS 0.24
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.11
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.45

Current Ratio 1.45
Quick Ratio 1.19
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -9.54

Financial Efficiency

Return on equity (ROE) is -1,921.20% and return on invested capital (ROIC) is -80.88%.

Return on Equity (ROE) -1,921.20%
Return on Assets (ROA) -69.80%
Return on Capital (ROIC) -80.88%
Revenue Per Employee $125,502
Profits Per Employee -$139,890
Employee Count 444
Asset Turnover 0.63
Inventory Turnover 10.14

Taxes

Income Tax -63,173
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.70% in the last 52 weeks. The beta is -0.81, so Centogene's price volatility has been lower than the market average.

Beta (1Y) -0.81
52-Week Price Change -37.70%
50-Day Moving Average 0.69
200-Day Moving Average 1.03
Relative Strength Index (RSI) 29.18
Average Volume (30 Days) 59,598

Short Selling Information

Short Interest 11,867
Short Previous Month 11,306
Short % of Shares Out 0.10%
Short % of Float n/a
Short Ratio (days to cover) 0.16

Income Statement

In the last 12 months, Centogene had revenue of $55.72 million and -$62.11 million in losses. Loss per share was -$1.55.

Revenue 55.72M
Gross Profit 21.74M
Operating Income -38.69M
Pretax Income -60.58M
Net Income -62.11M
EBITDA -43.72M
EBIT -54.83M
Loss Per Share -$1.55
Full Income Statement

Balance Sheet

The company has $15.15 million in cash and $64.14 million in debt, giving a net cash position of -$48.99 million or -$1.76 per share.

Cash & Cash Equivalents 15.15M
Total Debt 64.14M
Net Cash -48.99M
Net Cash Per Share -$1.76
Equity / Book Value -16.30M
Book Value Per Share -0.58
Working Capital 12.86M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$28.36 million and capital expenditures $522,586, giving a free cash flow of -$27.84 million.

Operating Cash Flow -28.36M
Capital Expenditures 522,586
Free Cash Flow -27.84M
FCF Per Share -$1.01
Full Cash Flow Statement

Margins

Gross margin is 39.01%, with operating and profit margins of -69.44% and -111.46%.

Gross Margin 39.01%
Operating Margin -69.44%
Pretax Margin -108.72%
Profit Margin -111.46%
EBITDA Margin -78.47%
EBIT Margin -98.40%
FCF Margin -49.96%

Dividends & Yields

Centogene does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -22.59%
Shareholder Yield -22.59%
Earnings Yield -483.50%
FCF Yield -216.71%

Analyst Forecast

The average price target for Centogene is $1.50, which is 225.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target $1.50
Price Target Difference 225.38%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Centogene has an Altman Z-Score of -4.55 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.55
Piotroski F-Score 4